SPRIM Global Investments is a privately held company that was established in 2008 as a global expansion of SPRIM Consulting & Services. They specialize in investing in companies that provide R&D capabilities to bring life science innovations to patients worldwide. Their portfolio includes a range of R&D Services and digital technology companies that address the pain points experienced by Biotech, Medtech, and CRO companies throughout the different clinical stages of drug and device development.

SPRIM Global Investments offers flexible investment strategies, including equity and debt through specialized vehicles such as Direct Equity Investments, Trial Cap Venture Debt Financing, and Venture Fund. Their portfolio companies benefit from the capabilities and network of SPRIM Global Investments in R&D Services/CRO, Healthcare IT, and digital solutions, with a presence in 17 strategically located offices across the Americas, Asia-Pacific, and Europe. With a focus on investing in the future of health, SPRIM Global Investments is committed to supporting innovation and driving positive change in the life sciences industry.

Contact them at their New York or Singapore office locations to learn more about their investment opportunities